Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

June 13, 2022

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2025

Conditions
Small Cell Lung Cancer
Interventions
RADIATION

Dose-escalated adaptive radiotherapy

Adaptive planning of Radiation Therapy with two re-plans of the treatment field through course of therapy with the shrinking treatment fields according to tumor response to escalate dose, as allowed by dose to organs-at-risk.

DRUG

Chemotherapy

Concurrent standard of care platinum doublet based therapy

Trial Locations (1)

T6G 1Z2

RECRUITING

Cross Cancer Institute, Edmonton

All Listed Sponsors
lead

AHS Cancer Control Alberta

OTHER